Insider Shareholders with Direct Ownership of Metacrine, Inc. (MTCR)
This section provides a comprehensive overview of the insiders with direct ownership of Metacrine, Inc. (MTCR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Metacrine, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
New Enterprise Associates 16, L.P.
> 10% Shareholder |
0 | 497,270 | 2,563,257 $0 | 2 |
Dec 22, 2021
Reduced 6.25%
|
|
Ven Bio Global Strategic Fund, L.P.
> 10% Shareholder |
0 | 615,702 | 2,443,421 $0 | 2 |
Oct 25, 2021
Reduced 18.12%
|
|
Preston Klassen
Director |
967,258 | 1,267,564 | 1,384,116 $0 | 6 |
Mar 23, 2023
Reduced 37.83%
|
|
Michael York
Chief Business Officer |
210,553 | 107,054 | 103,499 $0 | 2 |
Jan 26, 2023
Reduced 50.84%
|
|
Trisha Millican
Chief Financial Officer |
759 | 0 | 41,792 $0 | 1 |
May 05, 2021
Added 1.78%
|
|
Catherine Chai Zon Lee
EVP, Gen. Counsel & Secretary |
3,846 | 0 | 3,846 $0 | 1 |
May 05, 2021
Added 50.0%
|
|
Hubert C Chen
Chief Medical Officer |
3,289 | 0 | 3,289 $0 | 1 |
May 20, 2021
Added 50.0%
|